Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibition.

MLA

Achoui, Dalila, et al. “Early Postnatal Behavioral, Cellular, and Molecular Changes in Models of Huntington Disease Are Reversible by HDAC Inhibition.” Proceedings of the National Academy of Sciences of the United States of America, vol. 115, no. 37, Sept. 2018, pp. E8765–74. EBSCOhost, https://doi.org/10.1073/pnas.1807962115.

APA

Achoui, D., Siebzehnrübl, F. A., Steindler, D. A., Aigner, L., Couillard-Despres, S., Paucar, M. A., Svenningsson, P., Osmand, A., Andreew, A., Zabel, C., Weiss, A., Kuhn, R., Moussaoui, S., Blockx, I., Van der Linden, A., Cheong, R. Y., Petersén, Å., Roybon, L., Gupta, B., & Raber, K. A. (2018). Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibition. Proceedings of the National Academy of Sciences of the United States of America, 115(37), E8765–E8774. https://doi.org/10.1073/pnas.1807962115

Chicago

Achoui, Dalila, Florian A. Siebzehnrübl, Dennis A. Steindler, Ludwig Aigner, Sebastien Couillard-Despres, Martin Arce Paucar, Per Svenningsson, et al. 2018. “Early Postnatal Behavioral, Cellular, and Molecular Changes in Models of Huntington Disease Are Reversible by HDAC Inhibition.” Proceedings of the National Academy of Sciences of the United States of America 115 (37): E8765–74. doi:10.1073/pnas.1807962115.